is teaming up with Duke University's
Institute for Genome Sciences & Policy
to launch a joint research effort designed to develop new genomic tests.
Geoffrey Ginsburg, a holder of an MD and PhD, will lead the Duke-LabCorp Scholars in Genomic Medicine program. Ginsburg is a member of the Duke Institute for Genome Sciences & Policy faculty.
North Carolina-based LabCorp is one of the largest provider of medical testing services in the country.
The program will focus on advanced research into clinical testing applications for genomic medicine. The intent is to commercialize tests "as rapidly as possible", Duke and LabCorp said in a statement.
"Duke is a preeminent university, and their program in genomic medicine is one of the best in the country," said Myla Lai-Goldman, executive vice president, chief scientific officer and medical director of LabCorp.
"This collaboration supports our ever-growing menu of esoteric and genomic tests and underscores our commitment to work in a variety of ways with academia to bring forth new and relevant clinical tests."
Copyright 2024 by Capitol Broadcasting Company. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
